Information session on Brexit

Welcome to an information session on Brexit & medicines

On the afternoon of February 5, 2018, the Swedish Medical Products Agency will hold an information session on how Brexit will affect drug approvals.

The aim is to provide a status update and practical information; there will also be an opportunity to ask questions.

Read more and register here!